Chromadex Corp

CDXC.US
Healthcare · Biotechnology
Price N/A
USD · NASDAQ

Company Information

Company Name
Chromadex Corp
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US1710774076
CIK: 0001386570
CUSIP: 171077407
Currency: USD
Full Time Employees: 104
Phone: 310 388 6706
Fiscal Year End: December
IPO Date: Jul 15, 2008
Description:

ChromaDex Corporation operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Address:

10900 Wilshire Blvd, Los Angeles, CA, United States, 90024

People

Directors & Officers

Name Title Year Born
Mr. Frank Louis Jaksch Jr. Co-Founder & Chairman 1968
Mr. Ozan Pamir C.F.A. CFO & Principal Accounting Officer 1992
Dr. Andrew Shao Ph.D. Senior Vice President of Global Regulatory & Scientific Affairs NA
Mr. Carlos Lopez Senior VP & General Counsel NA
Ms. Michiko Kelley Chief Marketing Officer NA
Kendall Knysch Head of Media Relations & Partnerships NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 13, 2024 Frank L Jaksch Jr N/A Sale 37.16K $6.19 $230.03K
Nov 22, 2024 Ozan Pamir N/A Purchase 2.91K $7.36 $21.40K
Aug 23, 2024 Kristin Patrick N/A Sale 23.00K $3.57 $82.11K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.62M Mar 31, 2025 4.60% $0.00 0.15%
Vanguard Group Inc 3.54M Mar 31, 2025 4.50% $0.00 4.46%
Tieton Capital Management, LLC 1.99M Mar 31, 2025 2.52% $6.26 -23.28%
ICONIQ Capital, LLC 1.30M Dec 31, 2024 1.65% $0.11 0.00%
Geode Capital Management, LLC 1.15M Dec 31, 2024 1.47% $0.00 0.45%
D. E. Shaw & Co LP 1.01M Dec 31, 2024 1.29% $0.00 1,785.86%
State Street Corp 927.24K Mar 31, 2025 1.18% $0.00 1.34%
Qube Research & Technologies 709.57K Mar 31, 2025 0.90% $0.01 104.54%
Arrowstreet Capital Limited Partnership 662.96K Dec 31, 2024 0.84% $0.00 288.13%
Renaissance Technologies Corp 523.10K Mar 31, 2025 0.66% $0.01 -26.61%
Connor Clark & Lunn Inv Mgmt Ltd 506.19K Dec 31, 2024 0.64% $0.01 188.97%
Northern Trust Corp 429.87K Dec 31, 2024 0.55% $0.00 13.81%
AQR Capital Management LLC 352.14K Mar 31, 2025 0.45% $0.00 1,450.51%
Ameriprise Financial Inc 329.99K Dec 31, 2024 0.42% $0.00 212.52%
Cubist Systematic Strategies, LLC 310.37K Dec 31, 2024 0.39% $0.01 0.00%
JPMorgan Chase & Co 293.30K Mar 31, 2025 0.37% $0.00 -14.05%
Goldman Sachs Group Inc 267.41K Mar 31, 2025 0.34% $0.00 56.31%
Hillsdale Investment Management Inc. 244.77K Mar 31, 2025 0.31% $0.09 0.00%
Millennium Management LLC 226.09K Dec 31, 2024 0.29% $0.00 0.00%
Victory Capital Management Inc. 222.68K Mar 31, 2025 0.28% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 2.12M 2.70% ▲ 0.00% Mar 31, 2025
2 Tieton Small Cap Value 1.99M 2.52% ▼ 23.28% Mar 31, 2025
3 iShares Russell 2000 ETF 1.25M 1.59% ▲ 0.02% Apr 30, 2025
4 Vanguard Institutional Extnd Mkt Idx Tr 819.53K 1.04% ▲ 2.54% Mar 31, 2025
5 Fidelity Small Cap Index 489.59K 0.62% ▲ 0.00% Feb 28, 2025
6 Pleiades Small Cap Equity A 487.55K 0.62% ▼ 20.95% Mar 31, 2025
7 iShares Russell 2000 Growth ETF 442.77K 0.56% ▲ 0.00% Apr 30, 2025
8 Invesco Dorsey Wright SmallCap Momt ETF 325.64K 0.41% ▲ 0.00% Apr 30, 2025
9 Fidelity Extended Market Index 292.17K 0.37% ▲ 1.80% Mar 31, 2025
10 State St Russell Sm/Mid Cp® Indx SL Cl I 282.24K 0.36% ▲ 0.52% Apr 30, 2025

Financial Highlights

Market Cap: $611.90M
EBITDA: $8.54M
P/E Ratio: $71.55
PEG Ratio: $0.00
Book Value: $0.60
Earnings/Share: $0.11
Profit Margin: 8.59%
Operating Margin: 24.42%
ROA (TTM): 7.84%
ROE (TTM): 22.94%
Revenue (TTM): $99.60M
Revenue/Share (TTM): $1.31
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 37.40%

Valuation Metrics

Enterprise Value: $483.74M
Trailing P/E: 71.55
Forward P/E: 56.18

Shares Statistics

Shares Outstanding: 77.75M
Shares Float: 50.84M
% Insiders: 3,479.20%
% Institutions: 3,000.10%
Short % Float: 4.18%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$61.59M
Cost of Goods Sold
adjust
$-38.01M
Gross Profit
subtotal
$61.59M
SG&A
adjust
$-18.38M
R&D
adjust
$-6.02M
Other Operating Expense
adjust
$-29.47M
Operating Income
subtotal
$7.73M
Other / Non-Operating Items
adjust
$824.00K
Net Income
subtotal
$8.55M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CDXC.US!